National rates of antiplatelet therapy in Medicare beneficiaries with heart failure and coexisting coronary artery disease

被引：0
|
作者：
Masoudi, FA
Havranek, EP
Wolfe, P
Westfall, KA
Ordin, DL
Krumholz, HM
机构：
[1] Denver Hlth Med Ctr, Denver, CO USA
[2] CFMC, Denver, CO USA
[3] Univ Colorado, Hlth Sci Ctr, Denver, CO USA
[4] CMS, Boston, MA USA
[5] Yale Univ, Sch Med, New Haven, CT USA
来源：
AMERICAN HEART JOURNAL | 2002年 / 144卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
83
引用
收藏
页码：916 / 916
页数：1
相关论文
共 50 条
  • [31] Predicting Costs Among Medicare Beneficiaries With Heart Failure
    Greiner, Melissa A.
    Hammill, Bradley G.
    Fonarow, Gregg C.
    Whellan, David J.
    Eapen, Zubin J.
    Hernandez, Adrian F.
    Curtis, Lesley H.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (05): : 705 - 711
  • [32] ARE MEDICARE BENEFICIARIES WITH HEART FAILURE RECEIVING RECOMMENDED TREATMENT?
    Dutcher, S. K.
    Zuckerman, I. H.
    Rattinger, G. B.
    Chhabra, P. T.
    Gottlieb, S. S.
    Simoni-Wastila, L.
    Stuart, B.
    [J]. GERONTOLOGIST, 2011, 51 : 9 - 9
  • [33] Economic burden of hospitalizations of Medicare beneficiaries with heart failure
    Kilgore, Meredith
    Patel, Harshali K.
    Kielhorn, Adrian
    Maya, Juan F.
    Sharma, Pradeep
    [J]. RISK MANAGEMENT AND HEALTHCARE POLICY, 2017, 10 : 63 - 70
  • [34] OUTCOMES OF MEDICARE BENEFICIARIES WITH HEART FAILURE AND ATRIAL FIBRILLATION
    Khazanie, Prateeti
    Liang, Li
    Qualls, Laura
    Curtis, Lesley
    Fonarow, Gregg
    Hammill, Bradley
    Hammill, Stephen
    Heidenreich, Paul
    Masoudi, Frederick
    Hernandez, Adrian
    Piccini, Jonathan
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E733 - E733
  • [35] Dual Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease and Peripheral Artery Disease Patients
    Mackman, Nigel
    Spronk, Henri M. H.
    Stouffer, George A.
    ten Cate, Hugo
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (04) : 726 - 732
  • [36] Republished: Antiplatelet therapy for secondary prevention of coronary artery disease
    Pilgrim, Thomas
    Windecker, Stephan
    [J]. POSTGRADUATE MEDICAL JOURNAL, 2015, 91 (1075) : 284 - 290
  • [37] Optimal duration of dual antiplatelet therapy for coronary artery disease
    Kikkert, W. J.
    Damman, P.
    [J]. NETHERLANDS HEART JOURNAL, 2018, 26 (06) : 321 - 333
  • [38] Tailoring antiplatelet therapy in older patients with coronary artery disease
    Kovacevic, Mila
    Pompei, Graziella
    Kunadian, Vijay
    [J]. PLATELETS, 2023, 34 (01)
  • [39] Platelets and Antiplatelet Therapy in Patients with Coronary Artery Disease and Diabetes
    Neergaard-Petersen, Sos
    Hvas, Anne-Mette
    Kristensen, Steen Dalby
    Grove, Erik Lerkevang
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2016, 42 (03): : 234 - 241
  • [40] The role of antiplatelet therapy in the secondary prevention of coronary artery disease
    Behan, Miles W.
    Chew, Derek P.
    Aylward, Philip E.
    [J]. CURRENT OPINION IN CARDIOLOGY, 2010, 25 (04) : 321 - 328
12345